Healthcare provider profile · identity verified

Padmalatha Dharanikota, MD

Internal Medicine · RICHMOND, VA · NPI 1922099720

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	517	124
Eliquis	Apixaban	378	53
Amlodipine Besylate	Amlodipine Besylate	363	72
Levothyroxine Sodium	Levothyroxine Sodium	288	69
Furosemide	Furosemide	248	59
Latanoprost	Latanoprost	201	29
Donepezil Hcl	Donepezil Hcl	196	43
Sertraline Hcl	Sertraline Hcl	194	44
Memantine Hcl	Memantine Hcl	185	37
Trazodone Hcl	Trazodone Hcl	179	41
Losartan Potassium	Losartan Potassium	176	41
Mirtazapine	Mirtazapine	169	36
Metoprolol Succinate	Metoprolol Succinate	161	39
Carvedilol	Carvedilol	158	35
Metoprolol Tartrate	Metoprolol Tartrate	154	35
Tamsulosin Hcl	Tamsulosin Hcl	153	41
Finasteride	Finasteride	143	29
Hydralazine Hcl	Hydralazine Hcl	139	24
Potassium Chloride	Potassium Chloride	135	37
Pantoprazole Sodium	Pantoprazole Sodium	131	29
Trulicity	Dulaglutide	129	suppressed
Clopidogrel	Clopidogrel Bisulfate	127	34
Lisinopril	Lisinopril	123	27
Omeprazole	Omeprazole	111	50
Bumetanide	Bumetanide	108	31
Quetiapine Fumarate	Quetiapine Fumarate	107	31
Buspirone Hcl	Buspirone Hcl	104	24
Famotidine	Famotidine	98	26
Gabapentin	Gabapentin	94	50
Simvastatin	Simvastatin	86	16
Diclofenac Sodium	Diclofenac Sodium	85	33
Pravastatin Sodium	Pravastatin Sodium	75	19
Ondansetron Hcl	Ondansetron Hcl	73	25
Duloxetine Hcl	Duloxetine Hcl	70	24
Prednisone	Prednisone	68	23
Escitalopram Oxalate	Escitalopram Oxalate	66	16
Fluticasone Propionate	Fluticasone Propionate	63	30
Metformin Hcl	Metformin Hcl	63	19
Spironolactone	Spironolactone	60	17
Levetiracetam	Levetiracetam	59	16
Ipratropium-Albuterol	Ipratropium/Albuterol Sulfate	58	14
Montelukast Sodium	Montelukast Sodium	58	17
Divalproex Sodium	Divalproex Sodium	57	11
Amiodarone Hcl	Amiodarone Hcl	56	19
Hydrochlorothiazide	Hydrochlorothiazide	55	11
Citalopram Hbr	Citalopram Hydrobromide	53	suppressed
Xarelto	Rivaroxaban	51	suppressed
Allopurinol	Allopurinol	50	13
Timolol Maleate	Timolol Maleate	50	suppressed
Klor-Con 10	Potassium Chloride	48	suppressed
Rosuvastatin Calcium	Rosuvastatin Calcium	45	13
Digoxin	Digoxin	44	suppressed
Amitriptyline Hcl	Amitriptyline Hcl	43	suppressed
Baclofen	Baclofen	42	suppressed
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	42	12
Oxycodone Hcl	Oxycodone Hcl	42	29
Venlafaxine Hcl Er	Venlafaxine Hcl	42	suppressed
Brimonidine Tartrate	Brimonidine Tartrate	41	suppressed
Entresto	Sacubitril/Valsartan	41	suppressed
Labetalol Hcl	Labetalol Hcl	41	suppressed
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	40	11
Oxybutynin Chloride	Oxybutynin Chloride	40	suppressed
Dorzolamide Hcl	Dorzolamide Hcl	39	suppressed
Spiriva Respimat	Tiotropium Bromide	37	suppressed
Basaglar Kwikpen U-100	Insulin Glargine,hum.Rec.Anlog	36	suppressed
Jardiance	Empagliflozin	36	suppressed
Albuterol Sulfate Hfa	Albuterol Sulfate	35	16
Carbamazepine	Carbamazepine	35	suppressed
Ezetimibe	Ezetimibe	35	suppressed
Insulin Lispro Kwikpen U-100	Insulin Lispro	35	suppressed
Lamotrigine	Lamotrigine	34	suppressed
Myrbetriq	Mirabegron	34	suppressed
Insulin Glargine-Yfgn	Insulin Glargine-Yfgn	33	12
Tramadol Hcl	Tramadol Hcl	32	24
Esomeprazole Magnesium	Esomeprazole Magnesium	31	suppressed
Calcitriol	Calcitriol	30	suppressed
Carbidopa-Levodopa	Carbidopa/Levodopa	29	suppressed
Fluoxetine Hcl	Fluoxetine Hcl	28	suppressed
Isosorbide Mononitrate Er	Isosorbide Mononitrate	28	11
Midodrine Hcl	Midodrine Hcl	27	17
Spiriva Handihaler	Tiotropium Bromide	27	suppressed
Dorzolamide-Timolol	Dorzolamide Hcl/Timolol Maleat	25	suppressed
Rasagiline Mesylate	Rasagiline Mesylate	25	suppressed
Atenolol	Atenolol	24	suppressed
Cephalexin	Cephalexin	24	13
Methenamine Hippurate	Methenamine Hippurate	24	suppressed
Nystatin	Nystatin	24	17
Paroxetine Hcl	Paroxetine Hcl	24	suppressed
Lactulose	Lactulose	23	suppressed
Pramipexole Dihydrochloride	Pramipexole Di-Hcl	23	suppressed
Folic Acid	Folic Acid	22	suppressed
Humulin N Kwikpen	Insulin Nph Human Isophane	22	suppressed
Clonidine	Clonidine	21	suppressed
Levocetirizine Dihydrochloride	Levocetirizine Dihydrochloride	21	suppressed
Travoprost	Travoprost	21	suppressed
Aripiprazole	Aripiprazole	20	suppressed
Bupropion Xl	Bupropion Hcl	20	suppressed
Restasis	Cyclosporine	20	suppressed
Sucralfate	Sucralfate	20	suppressed
Budesonide	Budesonide	19	suppressed
Celecoxib	Celecoxib	19	suppressed
Cinacalcet Hcl	Cinacalcet Hcl	19	suppressed
Estradiol	Estradiol	19	suppressed
Zolpidem Tartrate	Zolpidem Tartrate	19	suppressed
Albuterol Sulfate	Albuterol Sulfate	18	suppressed
Azelastine Hcl	Azelastine Hcl	18	suppressed
Brinzolamide	Brinzolamide	18	suppressed
Lorazepam	Lorazepam	18	15
Olanzapine	Olanzapine	18	suppressed
Ranolazine Er	Ranolazine	18	suppressed
Tresiba Flextouch U-100	Insulin Degludec	18	suppressed
Carbidopa-Levodopa Er	Carbidopa/Levodopa	17	suppressed
Insulin Lispro	Insulin Lispro	17	suppressed
Metformin Hcl Er	Metformin Hcl	17	suppressed
Pregabalin	Pregabalin	17	suppressed
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	17	suppressed
Wixela Inhub	Fluticasone Propion/Salmeterol	17	suppressed
Loperamide	Loperamide Hcl	16	suppressed
Meropenem-0.9% Nacl	Meropenem-0.9% Sodium Chloride	16	suppressed
Ondansetron Odt	Ondansetron	16	13
Ropinirole Hcl	Ropinirole Hcl	16	suppressed
Azithromycin	Azithromycin	15	suppressed
Breztri Aerosphere	Budesonide/Glycopyr/Formoterol	15	suppressed
Chlorthalidone	Chlorthalidone	15	suppressed
Glimepiride	Glimepiride	15	suppressed
Lokelma	Sodium Zirconium Cyclosilicate	15	suppressed
Doxycycline Hyclate	Doxycycline Hyclate	14	14
Januvia	Sitagliptin Phosphate	14	suppressed
Linzess	Linaclotide	14	suppressed
Autoshield Duo Pen Needle	Pen Needle,dual Safety,diabetc	13	suppressed
Ciprofloxacin Hcl	Ciprofloxacin Hcl	13	suppressed
Diltiazem 24hr Er (Xr)	Diltiazem Hcl	13	suppressed
Fosfomycin Tromethamine	Fosfomycin Tromethamine	13	suppressed
Levofloxacin	Levofloxacin	13	11
Oxybutynin Chloride Er	Oxybutynin Chloride	13	suppressed
Tolterodine Tartrate	Tolterodine Tartrate	13	suppressed
Triamcinolone Acetonide	Triamcinolone Acetonide	13	suppressed
Alendronate Sodium	Alendronate Sodium	12	suppressed
Ammonium Lactate	Ammonium Lactate	12	suppressed
Breyna	Budesonide/Formoterol Fumarate	12	suppressed
Ipratropium Bromide	Ipratropium Bromide	12	suppressed
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	12	suppressed
Medroxyprogesterone Acetate	Medroxyprogesterone Acetate	12	suppressed
Mycophenolate Mofetil	Mycophenolate Mofetil	12	suppressed
Nitroglycerin	Nitroglycerin	12	suppressed
Sodium Chloride	0.9 % Sodium Chloride	12	suppressed
Topiramate	Topiramate	12	suppressed
Amantadine	Amantadine Hcl	11	suppressed
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	11	suppressed
Arnuity Ellipta	Fluticasone Furoate	11	suppressed
Isosorbide Dinitrate	Isosorbide Dinitrate	11	suppressed
Olmesartan Medoxomil	Olmesartan Medoxomil	11	suppressed
Pyridostigmine Bromide	Pyridostigmine Bromide	11	suppressed
Semglee (Yfgn) Pen	Insulin Glargine-Yfgn	11	suppressed
Zafirlukast	Zafirlukast	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error